Lupin Limited has informed the Exchange regarding a press release dated February 01, 2024, titled "Lupin Receives Approval from U.S. FDA for Dronedarone Tablets, USP.
Lupin Limited has informed the Exchange regarding a press release dated February 01, 2024, titled "Lupin Receives Approval from U.S. FDA for Dronedarone Tablets, USP.